Sox factors function as either activators or repressors of b-catenin/TCF transcription depending on the cellular context and associated interacting proteins. Our previous study provided evidence that alteration in b-catenin signaling is an essential event during transdifferentiation toward the morular phenotype of endometrial carcinomas (Em Cas). Here, we focused on related functional roles of Sox factors. Of eight Sox factors investigated, Sox4 could enhance b-catenin/TCF4 transcription, through upregulation of TCF4 at the transcription level, without any direct b-catenin association. Cells stably overexpressing Sox4 showed significant decreases in proliferation rate, along with increases in expression of p21 WAF1 , as well as TCF4, in contrast to increased cell growth observed with knockdown. Of these factors, only Sox7 could transcriptionally upregulate Sox4 expression, but it also resulted in not only inhibition of Sox4-meditated activation of b-catenin/TCF4-driven transcription, but also repression of its own promoter activity, indicating the existence of very complex feedback loop for Sox-mediated signal cascades. Finally, Sox4 immunoreactivity was frequently pronounced in morular lesions of Em Cas, the expression being positively correlated with status of b-catenin, TCF4, and Sox7, and inversely with cell proliferation. These data therefore suggest that Sox4 may serve as a positive regulator of b-catenin signaling through alteration in TCF4 expression during morular differentiation of Em Ca cells, leading to inhibition of cell proliferation. In addition, Sox7 may also participate in the process, having complex roles in modulation of signaling.
The sex-determining region Y (Sry) box or Sox factors, comprising 20 highly conserved transcription molecules that have important roles in diverse developmental process in most vertebrates, feature two functional domains: an Sryrelated high-mobility group (HMG) box, located in the N-terminal half of the protein, and a transactivation domain, located at the C terminus. [1] [2] [3] On the basis of protein sequence comparisons, Sox factors are divided into eight groups, A-H, and those within each subgroup share conserved structural domains outside the HMG domain, functioning as either transcriptional activators or repressors depending on the cellular context and associated interacting proteins. 4, 5 Sox4, a member of the SoxC group, preferentially binds to the A/T A/T CAAA T/G DNA motif and induces bending of DNA, thus facilitating protein-protein or protein-DNA interactions. 6, 7 In general, its expression is high in embryonic neural progenitors and mesenchymal cells in many developing organs, but becomes more restricted after birth, as cells reach their final differentiation state. 8 However, upregulation is observed in response to progestin through progesterone receptor binding to the gene in mammary glands and uterus of mice, 9, 10 and overexpression has been reported in a variety of human malignancies, such as leukemias, melanomas, glioblastomas, and cancers of the prostate, bladder, and lung, [11] [12] [13] although it remains to be clarified what roles the factor has in vivo and during tumorigenesis.
Focal squamous differentiation into a morular phenotype in endometrial carcinomas (Em Cas) is considered to be linked with an increased probability of survival, implying that the elucidation of the mechanisms may provide clues in understanding of biological behavior. [14] [15] [16] Our previous studies revealed that accumulation of b-catenin in nuclei may have an essential role in an induction of transdifferentiation toward morular phenotype of Em Ca cells, leading to inhibition of cell proliferation through cooperation with other many signaling pathways. [17] [18] [19] [20] Given the documented possible roles of Sox4, as well as other Sox factors, in b-catenin/TCF-driven transcription, 21 we hypothesized that the factor may also contribute to the morular differentiation processes. To test this, we investigated here Sox4 expression, with reference to status of other Sox factors, b-catenin, TCF4, and cell proliferation, using Em Ca tissues and cell lines.
MATERIALS AND METHODS Plasmids, Cell Lines, and Antibodies
Full-length cDNAs of human Sox3, Sox4, Sox5, Sox6, Sox7, Sox9, and mouse Sox11 (Open Biosystems, Huntsville, AL, USA) with or without an HA tag were subcloned into pcDNA3.1 (Invitrogen, Carlsbad, CA, USA) and pEGFP vectors (BD Biosciences Clontech, Worcester, MA, USA). A full-length cDNA for human Sox17 (GenBank accession number NM022454) was also generated by PCR. The human Sox4 promoter (AL136179) between À2647 and þ 11 bp from transcription start site was amplified by PCR, and subcloned into the pGL-3B vector (Promega, Madison, WI, USA). The human Sox7 promoter (NM031439) between À1633 and À462 bp from translation start site was also generated using similar procedures, and a series of 5 0 -truncated promoter constructs of TCF4 and Sox7 genes were generated by PCR-and enzyme-digestion-based methods, as described previously. 19 Site-directed mutagenesis in putative Sox-binding sites in TCF4 gene was also carried out using Mega-PCR methods. 22 The identity of all constructs was confirmed by sequencing before use. The sequences of PCR primers employed in this study are listed in Supplementary  Table S1 . pcDNA3.1-HA-b-catenin DS45, pM-b-catenin, pG5-luc, pUSE-Myc-TCF4, pCI-Flag-p300, p21 WAF1 -luc, and Top reporter constructs were the same as described previously. [17] [18] [19] [20] Figure 1 mRNA expression of Sox factors in Em Ca cells. Left: mRNA expression of eight Sox factors in 11 Em Ca cell lines detected by RT-PCR assay. Right: relative amounts of the Sox mRNA expression levels calculated by normalization to signals for the GAPDH gene using NIH Image. 23, 24 To establish cells stably overexpressing HA-Sox4, expression plasmids or empty vectors were transfected into Ishikawa cells, and two independent clones were established, as described previously. 17, 20 Anti-Sox4 (ab52043) was supplied by Abcam (Cambridge, MA, USA). Anti-Sox7 (HPA009065), anti-TCF4 (HPA025958), anti-Flag M2, and anti-b-actin were from Sigma Chemical (St Louis, MO, USA). Anti-b-catenin was from Transduction Laboratories (Lexington, KY, USA), antip21 WAF1 and anti-Ki-67 were from Dako (Copenhagen, Denmark), and anti-HA and anti-Myc were from Santa Cruz Biotechnology (Santa Cruz, CA, USA).
Transfection
Transfection was carried out using Lipofectamine PLUS (Invitrogen) in duplicate or triplicate. Luciferase activity was assayed, as described previously. [17] [18] [19] [20] In addition, siRNAs for Sox4, as well as the negative controls, were transfected using siPORT NeoFX transfection agent (Ambion, Austin, TX) according to the manufacturers' instructions. 25 
RT-PCR
Amplification was carried out in the exponential phase (20-28 cycles) to allow comparison among cDNAs synthesized from identical reactions, using specific primers (Supplementary Table S1 ). Primers for the GAPDH gene were also applied as described previously. [17] [18] [19] [20] The intensity of Immunofluorescence After transfection of GFP-Sox4, together with HA-b-catenin, Myc-TCF4, or Flag-p300, the cells were incubated with anti-b-catenin, anti-TCF4, anti-HA, anti-Myc, and anti-Flag antibodies, respectively. FITC-or rhodamine-labeled antirabbit IgGs (Molecular Probes, Leiden, The Netherlands) were used as secondary antibodies, as described previously.
17-20
Western Blot Assays Total cellular proteins were prepared using RIPA buffer (50 mM Tris-HCl (pH 7.2), 1% NP-40, 0.5% sodium deoxycholate, 0.1% SDS), and western blot assays were carried out as described previously.
Clinical Cases Histological findings were reviewed for hysterectomy specimens of endometrioid-type Em Cas in the case records of Kitasato University Hospital during the period from 2000 to 2008, according to the criteria of the 2003 World Health Organization classification. 26 Areas consisting of spindleshaped cells forming growth sheets were defined as morules, as described previously. [17] [18] [19] [20] Each Em Ca was also staged according to the 1988 International Federation of Gynecology and Obstetrics (FIGO) staging system. 27 A total of 48 cases of Em Cas without morules, including 29 of grade 1 (G1) and 19 of G2 or G3, as well as 25 of atypical hyperplasia (AH), were investigated. Of those available, 30 were subcategorized as stage I and 18 as stage II-IV, whereas 28 demonstrated upper invasion (less than half of the myometrial depth) and 20 lower invasion, as well as 10 for positive and 35 for negative nodal metastasis. A total of 38 cases of G1 tumors Sox4 and b-catenin in endometrial carcinomas M Saegusa et al with morules were also selected. In addition, 40 biopsy specimens of normal endometrial tissues, including 10 in the proliferative and 30 in secretory phases, were investigated, the latter being subclassified into 10 early and 20 middle and late phases, according to the criteria of Mutter et al. 28 All tissues were routinely fixed in 10% formalin and processed for embedding in paraffin wax. Approval for this study was given by the Ethics Committee of the Kitasato University School of Medicine (B07-16).
Immunohistochemistry
Immunohistochemistry was performed using a combination of the microwave-oven heating and polymer immunocomplex (Envision, Dako) methods, followed by evaluation, in terms of immunopositive nuclei counted, to allow calculation of labeling indices (LIs), as described previously. [17] [18] [19] [20] Sox7 Promoter Methylation Assay Genomic DNAs were treated by bisulfate using the EZ DNA Methylation-Gold Kit (ZYMO Research, Orange, CA, USA). Methylation-specific PCR for Sox7 promoter was carried out, as described by Guo et al. 29 
Statistics
Comparative data were analyzed using the Mann-Whitney U-test and the Spearman's correlation coefficient. The cutoff for statistical significance was set as Po0.05.
RESULTS
Activation of b-Catenin/TCF4-Driven Transcription by Sox4 in Em Ca Cells As Sox factors are frequently co-expressed, 2 we first examined these mRNA expression levels in 11 Em Ca cell lines. Relatively high mRNA expression for Sox3, Sox6, Sox9, Sox11, Table S1 ) primers were used. Lower: Ishikawa cells were transfected with the p21 WAF1 reporter constructs, together with Sox4. Relative activity was determined based on arbitrary light units of luciferase activity normalized to pRL-TK activity. The activities of the reporter plus the effector relative to that of the reporter plus empty vector are shown as means ± s.d.s.
The experiment was performed in duplicate.
Sox4 and b-catenin in endometrial carcinomas M Saegusa et al and Sox17 was observed in most cases, in contrast to low levels for Sox4, Sox5, and Sox7 (Figure 1 ), demonstrating significantly positive correlations among these, with the exception of Sox9 status (Table 1) . To examine whether Sox factors have an ability to alter b-catenin/TCF4-driven transcription in Em Ca cells, they were transfected into Ishikawa and Hec251 cells. Transient transfection of Sox4 caused an increase in a b-catenin/TCF4-mediated transcription activity determined by Top reporter constructs, whereas inhibition resulted with Sox3, Sox7, and Sox17 (Figure 2a and Supplementary Figure S1A) . The enhancing effects of Sox4 were completely abrogated by co-transfection of Sox7 (Figure 2b) , as well as of Sox3 and Sox17 (data not shown). To examine whether Sox4 is directly associated with b-catenin-dependent transcription, we conducted one hybrid assay using a DNA-BD-fused b-catenin fragment (pM-b-cat) in Ishikawa and Hec251 cells. As shown in Figure 2c and Supplementary Figure S1B , the pG5-luc activity was not altered by combination of pM-b-cat with Sox4, in contrast to p300, a known coactivator for b-catenin signaling. 18 In addition, Flag-p300 colocalized with b-catenin, forming aggregates in nuclei as described previously, 18 but this did not occur when Sox4 was combined with b-catenin as well as TCF4 (Figure 2d ).
Transcriptional Upregulation of TCF4 by Sox4
Our previous study demonstrated that transcription factor Egr1 participates in upstream regulation of b-catenin signaling through transactivation of the TCF4 gene in Em Ca cells. 19 To examine whether Sox4 is also involved in control of TCF4 expression, HA-Sox4 or GFP-Sox4 was transfected into Ishikawa and Hec251 cells. As shown in Figure 3a and Supplementary Figure S2A , the overexpression resulted in a significant increase in endogenous TCF4 expression at both mRNA and protein levels. Next, we noted a 1308 bp fragment upstream of the translation start site in the TCF4 gene (AF522996) to be highly GC rich, containing four potential binding sites for Sox factors (Figure 3b) , on the basis of previous data for the consensus binding sequence A/T A/T CAAA T/G. 6, 7 With a series of 5 0 -truncated promoter constructs (Figure 3c ), deletion from À1308 to À590 bp had little effect on induction of promoter activity by Sox4, but lack of À590 to À377 bp resulted in a decrease in responsiveness, indicating that Sox4-responsive elements might be Sox4 and b-catenin in endometrial carcinomas M Saegusa et al located in the region from À590 to À377 bp (Figure 3d) . Mutations in the putative Sox-responsive element site located between À432 to À426 bp caused significant decrease in responsiveness (Figure 3e ), indicating the seven nucleotides CTTTGAA to constitute a functional cis-acting element necessary for TCF4 promoter stimulation by Sox4. In contrast, such effects were relatively minor with the other Sox factors investigated (Supplementary Figure S2B) .
Relationship Between Sox4 and Cell Proliferation in Em Cas
In both Ishikawa and Hec251 cells, Sox4 protein expression was not altered during steady cell growth in the presence of serum, whereas considerable increase of Sox4, as well as TCF4 and p21
WAF1 , occurred with cell growth inhibition due to serum starvation (Figure 4a) . Inhibition of endogenous Sox4 by specific siRNAs caused a relatively increase in Ishikawa cell growth, along with decreased expression of TCF4 and p21 WAF1 (Figure 4b ), whereas cells stably overexpressing HASox4 in nuclei showed a low proliferation rate, particularity in the exponential growth phase, with increased amounts of the two proteins (Figure 4c ). In addition, the latter was also upregulated by transfection of Sox4 at both mRNA and protein levels, in line with the increased promoter activity (Figure 4d ).
Transcriptional Upregulation of Sox4 by Sox7
Given the frequent co-expression of Sox factors in most Em Ca cell lines (Figure 1) , we examined whether Sox4 Sox4 and b-catenin in endometrial carcinomas M Saegusa et al expression is affected by other Sox factors. Transfection of Sox7 resulted in activation of the Sox4 promoter about 6.5-fold, leading to the increased expression at both mRNA and protein levels, in contrast to Sox4, Sox5, Sox6, and Sox9 ( Figure 5a and Supplementary Figure S3A) . On the basis of the evidence that Sox4 promoter (AL136179) had four potential Sox-binding sites in the region between À2647 and À232 bp from the transcription start site, a series of 5 0 -truncated constructs was generated ( Figure 5b ). As shown in Figure 5c , the various deletions resulted in stepwise decrease in Sox7 responsiveness, indicating that multiple Sox7-responsive elements might be present in the promoter region. In contrast, transfection of Sox7 showed significant inhibition of its own promoter activity (Figure 5d and Supplementary Figure S3B ), but various deleted promoters resulted in stepwise restoration in the repression (Figure 5e ), indicating that the effects might be linked to interaction with the basic machinery at the promoter.
Immunohistochemistry Findings for Normal and Malignant Endometrium
To examine whether such associations also exist in tumor tissues, we compared the expression levels of Sox4, Sox7, b-catenin, TCF4, and Ki-67 in Em Cas with morules. As shown in Figure 6 , immunoreactivity for Sox4 and Sox7 was more frequently observed in morular as compared with surrounding glandular carcinoma lesions, the differences in LIs being significant. Similar findings were also observed in cases of nuclear b-catenin and TCF4 staining, as described previously. 17, 18 Average LI values for Sox4 were positively Sox4 and b-catenin in endometrial carcinomas M Saegusa et al correlated with LIs for Sox7, nuclear b-catenin, and TCF4, and inversely with Ki-67 LIs. Similar associations of LIs among Sox7, nuclear b-catenin, TCF4, and Ki-67 were also evident ( Table 2) . In Em Cas without morules, immunoreactions for Sox4 and Sox7 were significantly greater in G1 than G2/G3 tumors, as well as AH lesions, LIs in the latter being significantly associated with upper myometrial invasion and negative for nodal metastasis (Figure 7a ). In addition, Sox4 LIs were correlated positively with Sox7 LIs, and inversely with Ki-67 LIs in Em Cas (Table 3) .
In normal endometrium, Sox4 immunoreactivity could not be observed throughout the menstrual cycle, in contrast to the significantly higher LI values of Sox7 in epithelial but not stromal components in early secretory stage (Figure 7b ).
Hypermethylation of Sox7 Promoter in Em Cas
As hypermethylation of the Sox7 promoter has been reported to frequently occur in tumors, 29, 30 we also examined the methylation status in Em Cas for comparison with expression levels. Methylation-specific PCR assays revealed specific signals in seven of eight Em Ca cell lines, with apparent decreases in the mRNA expression levels (Figure 8a) . In clinical samples, the frequencies of promoter methylation showed stepwise increase from Em Cas with morules, through G1 to G2/3 tumors lacking such lesions (Table 4) , being negatively associated with Sox7 LI values (Figure 8b ). In contrast, such findings were not observed in 10 normal and 15 AH lesions investigated. 12, 32 In our Em Ca cell lines, inhibition of cell growth due to serum starvation leaded to an increase in Sox4 expression, whereas cells stably overexpressing Sox4 demonstrated a low proliferation rate, through transactivation of the p21 WAF1 gene. In addition, expression was significantly higher in G1 than G2/3 Em Cas, inversely correlating with cell proliferation. These findings indicate that Sox4 may serve as a negative modulator for cell proliferation in Em Cas, presumably associated with altered cell cycling. Interestingly, it is considered that Sox4 may act as a tumor suppressor and favorable prognostic factor in bladder and hepatocellular carcinomas, respectively. 12, 33 In line with earlier results for colon carcinoma cells, 21 overexpression of Sox4 caused enhancement of b-catenin/ TCF4-driven transcription, in contrast to inhibitory effects of Sox3, Sox7, and Sox17, in Em Ca cells. Given that Sox4 can directly interact with TCF4 via the respective HMG domains as shown by in vitro protein-binding assays, 34 we anticipated a formation of active transcriptional complexes containing b-catenin, TCF4, and Sox4, as demonstrated with combination of b-catenin and p300, 18 but such associations proved to be rare events in Em Ca cells. Interestingly, the three proteins are unable to form stable complexes in vitro, 32 and it was recently reported that transactivation of b-catenin signaling induced by Sox4 was due to stabilization of the b-catenin protein, rather than through induction of b-catenin transcription. 35 Several lines of evidence from the present study support the conclusion that TCF4 is under transcriptional control by Sox4. First, Sox4 immunoreactivity significantly overlapped nuclear staining of TCF4, as well as nuclear b-catenin, in morular lesions of Em Ca tissues, with a very significant positive correlation (r ¼ 0.67, Po0.0001). Second, transient transfection of Sox4 resulted in increased expression of the endogenous TCF4 gene at both mRNA and protein levels, in line with the results for cells stably overexpressing Sox4. Third, the TCF4 promoter was activated by transfection of Sox4, through a Sox-binding element located at À432 bp, as evidenced by inhibition of promoter activity by introducing a four-nucleotide alteration in the site, indicating regulation at the transcription level. Taken together with evidence that TCF3 can stabilize b-catenin protein through its competition with axin and APC, 36 our results suggest that transactivation of the TCF4 gene mediated by Sox4 may be the primary mechanism underlying activation of b-catenin/TCF4-driven transcription.
Furthermore, the present data provided the first evidence that Sox7 is a transcriptionally positive regulator of Sox4 expression from the following findings: (1) upregulation of endogenous Sox4 expression at both mRNA and protein levels by exogenous Sox7; (2) increased Sox4 promoter activity on transfection of Sox7; (3) significant overlap of immunoreactivity between Sox4 and Sox7 in Em Cas, particularity in morular lesions; and (4) occasional Sox7 promoter hypermethylation in G1 Em Cas with morular lesions, associated with relatively high levels of Sox4 expression as compared with G2/G3 tumors. In contrast to the cooperative function with Sox4, overexpression of Sox7 not only abrogated Sox4-mediated b-catenin/TCF4-driven transcription, but also inhibited its own promoter activity. Given the evidence that Sox7 can degrade active b-catenin protein by direct interaction, 28 it is likely that Sox7 may also function as a key factor for modulation of the signal cascade, contributing to a very complex feedback loop system. Further studies of this point are clearly warranted.
As an unexpected result of this study, Sox4 protein expression was not found in any stage of the menstrual cycle in normal endometrium, in contrast to the murine uterus where cyclic changes in mRNA expression occur in response to ovarian steroid hormones. 10 One reason for the discrepancy may be differences in detection using mRNAand the protein-based methods. In addition, the observed high levels of Sox7 expression in early secretory stage were also surprising, allowing us to speculate that the gene may be important for changes in cell kinetics from proliferative to secretory stages in normal endometrium, as ectopic expression of Sox7 in Sox-null cells has been demonstrated to inhibit cell proliferation. 30 Together, our observations suggest a model for functional roles of Sox4 in b-catenin/TCF4 signaling in Em Ca cells (Figure 9 ), dependent on upregulation of the TCF4 gene. Newly synthesized TCF4 binds to excess b-catenin, probably present due to gene mutations, 17, 19 and this in turn leads to transactivation of target genes, such as TCF4 and p14 ARF , (ref. 17, 18) resulting in induction of morular differentiation of Em Ca cells. In addition to many signaling, 31 Sox7 may also contribute to upregulation of Sox4 expression, exerting antagonistic effects on b-catenin/TCF4-driven transcription.
In conclusion, the present study provided compelling evidence of an association between Sox factors, in particular Sox4, and b-catenin-dependent signaling in establishment 
